findmyKOL

Jared Kravitz, MD

Basic profile

University of Tennessee at Knoxville

ORCIDNPI
RegionKnoxville, TN · SoutheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Jared Kravitz is a Respiratory physician affiliated with University of Tennessee at Knoxville. OpenAlex indexes 15 publications with 364 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
15publications

Distinct works indexed by OpenAlex, matched via ORCID.

364citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
43companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1940 Alcoa Hwy
Suite E-210
Knoxville, TN 379202244

Telephone

865-524-7471

Registry record last updated 22 Jul 2011.

View the NPPES registry record

Industry payments

43 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    41.8%
    Corticosteroid24.4%
    Trelegy Ellipta46%Breo Ellipta20%Fluticasone Propionate16%Symbicort7%Breztri Aerosphere7%Arnuity Ellipta3%
    Part D<11 patients
    Leukotriene Receptor Antagonist8.7%
    Montelukast Sodium100%
    Part D35 patients

    + 2 more classes in this area

  • Cancer & immunology

    25.3%
    Kinase inhibitor19.9%
    Ofev100%
    Part D42 patients
    Pyridone5.4%
    Pirfenidone100%
    Part D18 patients
  • Metabolism & gastrointestinal

    21.1%
    Corticosteroid7.9%
    Prednisone100%
    Part D30 patients
    Proton pump inhibitor7.4%
    Esomeprazole Magnesium52%Pantoprazole Sodium27%Omeprazole21%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)45.2% facility · 54.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”